(Q33504771)

English

Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

A Martoni

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Guaraldi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

E Piana

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

E Strocchi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

A Petralia

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

L Busutti

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

P Preti

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Robustelli

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Raimondi

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Ferrara

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Palomba

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Lelli

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

V Picece

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

E Recaldin

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Ambrosini

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Sarobba

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

A Farris

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

F Pannuti

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 October 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

31-38

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900065-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900065-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase-II clinical trial of 4'-epi-doxorubicin in advanced solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900065-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of high-dose epirubicin in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900065-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of high-dose epirubicin in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900065-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I-II study of high-dose epirubicin in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900065-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900065-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. A cross-over study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900065-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900065-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900065-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I-II study of vinorelbine (Navelbine) plus cisplatin in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900065-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900065-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900065-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(98)00065-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869105%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33504771&oldid=1983569838"